Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily… - The Lancet, 2019 - thelancet.com
Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

DNA methylation cancer biomarkers: translation to the clinic

WJ Locke, D Guanzon, C Ma, YJ Liew… - Frontiers in …, 2019 - frontiersin.org
Carcinogenesis is accompanied by widespread DNA methylation changes within the cell.
These changes are characterized by a globally hypomethylated genome with focal …

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

C Marth, F Landoni, S Mahner… - Annals of …, 2017 - annalsofoncology.org
Cervical cancer is the second most commonly diagnosed cancer and the third leading cause
of cancer death among females in less developed countries. There were an estimated 527 …

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?

C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

M Drolet, É Bénard, MC Boily, H Ali… - The Lancet infectious …, 2015 - thelancet.com
Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

The estimated lifetime probability of acquiring human papillomavirus in the United States

HW Chesson, EF Dunne, S Hariri… - Sexually transmitted …, 2014 - journals.lww.com
Background Estimates of the lifetime probability of acquiring human papillomavirus (HPV)
can help to quantify HPV incidence, illustrate how common HPV infection is, and highlight …

[PDF][PDF] Dendritic-cell-based therapeutic cancer vaccines

K Palucka, J Banchereau - Immunity, 2013 - cell.com
The past decade has seen tremendous developments in novel cancer therapies through the
targeting of tumor-cell-intrinsic pathways whose activity is linked to genetic alterations and …

Human papillomavirus molecular biology

ME Harden, K Munger - Mutation Research/Reviews in Mutation Research, 2017 - Elsevier
Human papillomaviruses are small DNA viruses with a tropism for squamous epithelia. A
unique aspect of human papillomavirus molecular biology involves dependence on the …

[HTML][HTML] Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden

D Hashim, E Genden, M Posner, M Hashibe… - Annals of …, 2019 - Elsevier
Survival from head and neck cancers (HNCs) of the lip, oral cavity, pharynx, and larynx has
increased by 10% over the past few decades. Little over half of patients who develop HNCs …